TABLE 1 LAMEA Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Antacids Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Antacids Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Proton Pump Inhibitors (PPIs) Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Proton Pump Inhibitors (PPIs) Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA H2 Receptor Blockers Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA H2 Receptor Blockers Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Pro-kinetic Agents Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Pro-kinetic Agents Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Gastroesophageal Reflux Disease Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Gastroesophageal Reflux Disease Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 15 Brazil Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 16 Brazil Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 17 Brazil Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 18 Brazil Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 19 Argentina Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 20 Argentina Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 21 Argentina Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 22 Argentina Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 23 UAE Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 24 UAE Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 25 UAE Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 26 UAE Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 27 Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 30 Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 31 South Africa Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 32 South Africa Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 33 South Africa Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 34 South Africa Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 35 Nigeria Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 36 Nigeria Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 37 Nigeria Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 38 Nigeria Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 39 Rest of LAMEA Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 40 Rest of LAMEA Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 41 Rest of LAMEA Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 42 Rest of LAMEA Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 43 Key Information – Takeda Pharmaceutical Company Limited
TABLE 44 KEY INFORMATION – AstraZeneca PLC
TABLE 45 Key Information – GlaxoSmithKline PLC
TABLE 46 Key information –Johnson & Johnson
TABLE 47 Key Information – Ironwood Pharmaceuticals, Inc.
TABLE 48 Key Information – Eisai Co., Ltd.
TABLE 49 Key Information – Medigus Ltd.
TABLE 50 Key Information – Sebela Pharmaceuticals
TABLE 51 Key Information – Phathom Pharmaceuticals, Inc.
TABLE 52 Key Information – Camber Pharmaceuticals, Inc.
List of Figures
FIG 1 Methodology for the research
Unique Offerings 